|
MLLT10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.962240E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.22780000000067E-05 |
| Normal-vs-Stage2 |
4.080300E-02 |
| Normal-vs-Stage3 |
4.274400E-02 |
| Normal-vs-Stage4 |
1.100580E-03 |
| Stage1-vs-Stage2 |
4.131800E-01 |
| Stage1-vs-Stage3 |
5.995000E-01 |
| Stage1-vs-Stage4 |
5.499000E-01 |
| Stage2-vs-Stage3 |
7.798600E-01 |
| Stage2-vs-Stage4 |
2.004600E-01 |
| Stage3-vs-Stage4 |
4.147200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.50530000000116E-05 |
| Normal-vs-AfricanAmerican |
3.118000E-03 |
| Normal-vs-Asian |
8.716800E-01 |
| Caucasian-vs-AfricanAmerican |
9.689200E-01 |
| Caucasian-vs-Asian |
1.494440E-01 |
| AfricanAmerican-vs-Asian |
1.941180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.96450000003556E-06 |
| Normal-vs-Female |
4.796200E-01 |
| Male-vs-Female |
2.295600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.299100E-03 |
| Normal-vs-Extreme_Weight |
2.94719999960336E-07 |
| Normal-vs-Obese |
5.828100E-04 |
| Normal-vs-Extreme_Obese |
1.637810E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.156400E-01 |
| Normal_Weight-vs-Obese |
8.544800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.209800E-01 |
| Extreme_Weight-vs-Obese |
1.610380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.902400E-01 |
| Obese-vs-Extreme_Obese |
7.678400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.144800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.196100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.51991999999268E-05 |
| Normal-vs-Age(81-100Yrs) |
3.60489999999825E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.982800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.770200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.983000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.332500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.378400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.562600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.847700E-04 |
| Normal-VS-Type2 PRCC |
5.53789999999665E-05 |
| Normal-VS-KIRP CIMP |
6.059900E-03 |
| Normal-VS-Unclassified PRCC |
2.333600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.675010E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.205000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.055000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.836000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.442200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.252200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.374900E-04 |
| Normal-vs-N1 |
3.547200E-01 |
| Normal-vs-N2 |
5.300900E-03 |
| N0-vs-N1 |
2.288400E-01 |
| N0-vs-N2 |
3.492400E-01 |
| N1-vs-N2 |
2.635400E-01 |
|
|
